SCHEMBL21716491

SCHEMBL21716491

c1ccc(-n2c3ccccc3c3ccc(-c4nc5ccccc5nc4-c4ccc(-n5c6ccccc6c6cc7ccc(-n8c9ccccc9c9ccc%10ccccc%10c98)cc7cc65)cc4)cc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.36
KDM4E B2RXH2 3/20 0.36
ATM Q13315 1/20 0.36
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33
PRSS1 P07477 1/20 0.33
ALDH1A1 P00352 5/20 0.32
LMNA P02545 4/20 0.32
GAA P10253 3/20 0.32
HPGD P15428 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
MAPK9 P45984 1/20 0.31
MAPK10 P53779 1/20 0.31
THRB P10828 1/20 0.31
NPSR1 Q6W5P4 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717226 0.95 KDM4E (0.35) L3MBTL1KDM4EATMF2F10
SCHEMBL21717016 0.95 F2 (0.34) L3MBTL1KDM4EATMF2F10
SCHEMBL21716959 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMF2F10
SCHEMBL21716749 0.93 KDM4E (0.34) L3MBTL1KDM4EATMF2F10
SCHEMBL21716290 0.93 KDM4E (0.34) L3MBTL1KDM4EATMF2F10
SCHEMBL21716439 0.93 L3MBTL1 (0.42) L3MBTL1KDM4EATMF2F10
SCHEMBL21716765 0.93 KDM4E (0.32) L3MBTL1KDM4EATMF2F10
SCHEMBL21716504 0.92 L3MBTL1 (0.33) L3MBTL1KDM4EATMALDH1A1LMNA
SCHEMBL21168848 0.92 L3MBTL1 (0.36) L3MBTL1KDM4EATMF2F10
SCHEMBL21716746 0.92 L3MBTL1 (0.35) L3MBTL1KDM4EATMF2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 L3MBTL1 1427/4885KDM4E 1813/4885ATM 3428/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 L3MBTL1 1427/4885KDM4E 1813/4885ATM 3428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.